The Dermatology Digest

FEBRUARY 29, 2024

In addition to helping make it professionally safe to seek support, the partnership advocates for work environments in which physicians and advanced practitioners feel valued and supported, cultures that embrace their health and well-being, and settings that enable them to deliver safe, quality patient care.

Partnerships 74

Partnerships Hospital Office Dermatology 74

Lipgloss and Aftershave

JANUARY 15, 2024

Cluff Named Chief Executive Officer and Patrick Johnson to Serve as Executive Chairman and Chief Innovation Officer of BioPhotas, Inc. Denise Ryan has been promoted to the position of Chief Clinical Affairs Officer. Wayne (Tony) May has been promoted to Chief Financial Officer and Treasurer. BioPhotas, Inc.,

Management 52

Management Therapy Sales Office 52

The Dermatology Digest

APRIL 3, 2024

Ligand Pharmaceuticals is launching Pelthos Therapeutics (Pelthos), a biopharmaceutical company, and has appointed Scott Plesha as Chief Executive Officer to accelerate the commercialization of berdazimer topical gel, 10.3% (Zelsuvmi) for the treatment of molluscum contagiosum. Pelthos is a wholly owned subsidiary of Ligand.

Pharmaceutical 36

Pharmaceutical Sales Office Partnerships 36

The Dermatology Digest

APRIL 10, 2024

“The team has generated a strong preclinical data package that builds on the scientific community’s growing understanding of PKM2 and its role in the pathogenesis of atopic dermatitis,” says Lain Kilty, Chief Scientific Officer of Sitryx, in a news release.

Clinic 36

Clinic Office Partnerships Dermatitis 36

The Dermatology Digest

DECEMBER 20, 2023

Tim Raducha-Grace Named Chief Platform Officer at Zerigo Health Tim Raducha-Grace is the new Chief Platform Officer at Zerigo Health, a connected phototherapy platform that couples a handheld Narrow-band ultraviolet B (NB-UVB) light device with a smartphone app and team of care providers to allow patients to treat psoriasis and eczema at home.

Dermatology 36

Dermatology Surgery Eczema Office 36

The Dermatology Digest

FEBRUARY 27, 2024

Eric Hughes, Executive Vice President Global R&D and Chief Medical Officer at Teva, in a news release. This approval marks an important milestone for Teva and Alvotech’s partnership to collaborate on seven biosimilars and expand the availability, access, and uptake of biosimilars in the U.S.”

Safety 36

Safety Marketing Pharmaceutical Partnerships 36

The Dermatology Digest

JANUARY 16, 2024

Arash Khazei will step down as Chief Executive Officer, continuing in the near term as a strategic advisor to the company. Manufactured hucMSCs can be incorporated into certain licensed topical cosmetic products sold in the medical aesthetics skincare market. Meet miraDry’s New CEO Industry vet Rob Catlin is the new CEO at miraDry.

Dermatology 36

Dermatology Microneedling Technology Cosmetic Products 36

The Dermatology Digest

DECEMBER 21, 2023

and Europe will complement the recent launch of Nuceiva, our flagship neurotoxin, which has been met with very strong interest and growing demand from customers,” says David Moatazedi, President and Chief Executive Officer of Evolus, in a news release. “We We are extremely excited to expand our partnership with Evolus beyond the U.S.

Marketing 36

Marketing Sales Branding Portfolios 36

The Dermatology Digest

DECEMBER 21, 2023

and Europe will complement the recent launch of Nuceiva, our flagship neurotoxin, which has been met with very strong interest and growing demand from customers,” says David Moatazedi, President and Chief Executive Officer of Evolus, in a news release. “We We are extremely excited to expand our partnership with Evolus beyond the U.S.

Marketing 36

Marketing Sales Branding Portfolios 36

Aesthetics Advisor

JANUARY 28, 2024

Review I am over 65 and have taken medication that has a correlation to bone density loss for almost 20 years, so to get these results without prescription bone meds is miraculous. . - Through our partnership with rePurpose Global, we fund the recovery and processing of twice as much plastic waste from nature as we use in our bottle.

Vitamin C 36

Vitamin C Sustainability Ingredients Diet 36

Aesthetics Advisor

JANUARY 27, 2024

Review I am over 65 and have taken medication that has a correlation to bone density loss for almost 20 years, so to get these results without prescription bone meds is miraculous. . - Through our partnership with rePurpose Global, we fund the recovery and processing of twice as much plastic waste from nature as we use in our bottle.

Vitamin C 36

Vitamin C Sustainability Ingredients Diet 36

Aesthetics Advisor

SEPTEMBER 15, 2023

However, medications that are already authorized are just a small percentage of what's been studied. Many researchers are still trying to find and develop other medications that can treat or prevent COVID-19. It’s pure commonsense ,” Nathan Jones, chief executive officer of Xlear said in a statement.

Hospital 69

Hospital Clinic Marketing Medical 69

Aesthetics Advisor

FEBRUARY 1, 2024

Medical errors remain a leading cause of death in the U.S., 2 Describing diagnostic errors as "the most under-resourced public health crisis we face," researchers with Johns Hopkins School of Medicine said the public is largely unaware of the full scope of medical misdiagnoses in the U.S. 6 For instance, only about 1.5%

Medical 36

Medical Hospital Safety Training 36

US Dermatologt Partners

MAY 1, 2024

Dermatology Partners and The University of Texas at Tyler School of Medicine are proud to announce their partnership in establishing a new Department of Dermatology. By fostering collaboration, nurturing innovation, and demonstrating unwavering dedication, this partnership will lead the way in improving rural health outcomes.

Education 36

Education Dermatology Partnerships Innovations 36

Lipgloss and Aftershave

FEBRUARY 13, 2025

This expansion will provide CMed Aesthetics with office space, a dedicated manufacturing facility for skincare, and a separate facility for medical devices. Our adventure took off from the mid of 2018, when we found good partnerships in Poland, then Ukraine, UK and Russia at the end of the year.

Injections 92

Injections Social Media Innovations Skincare 92

Lipgloss and Aftershave

MARCH 13, 2025

If you’re as obsessed with high-performance, medical-grade formulations as we are, buckle up because this is a partnership thats about to shake up the skincare game. Every product is clean, non-toxic, and created to work harmoniously with in-office aesthetic treatments. Why Epicutis? The brand’s mission?

Branding 52

Branding Skincare Ingredients Microneedling 52

The Dermatology Digest

MARCH 27, 2025

We are thrilled to announce this agreement with Kaken, a dermatology leader with significant reach and expertise in the Japanese market, says Martin Babler, President and Chief Executive Officer of Alumis, in a news release. ESK-001 will be an important addition to the Kaken portfolio of novel therapeutics for dermatology conditions.

Pharmaceutical 36

Pharmaceutical Portfolios Clinic Safety 36

The Dermatology Digest

APRIL 16, 2025

Thats why through our Plan for Change weve taken action to boost our life sciences sector through steps to fast track clinical trials and cut red tape for researchers so that Britain is the best country in the world for medical research.

Hospital 72

Hospital Innovations Clinic Injections 72